German tariffs for the ICECAP-supportive care measure (ICECAP-SCM) for use in economic evaluations at the end of life

Article indépendant

DAMS, Judith | HUYNH, Elisabeth | RIEDEL-HELLER, Steffi | LOBNER, Margrit | BRETTSCHNEIDER, Christian | KONIG, Hans-Helmut

OBJECTIVES: Economic evaluations often use preference-based value sets (tariffs) for health-related quality of life to quantify health effects. For wellbeing at the end of life, issues beyond health-related quality of life may be important. Therefore, the ICECAP Supportive Care Measure (ICECAP-SCM), based on the capability approach, was developed. A validated German ICECAP-SCM version was published recently. However, tariffs for the German ICECAP-SCM are not available. Therefore, the aim was to determine tariffs for the ICECAP-SCM based on preferences of the German general population. METHODS: An online sample of 2996 participants completed a best-worst scaling (BWS) and a discrete choice experiment (DCE). BWSs required participants to choose the best and worst statement within the same capability state, whereas DCEs required participants to trade-off between two capability states. First, BWS and DCE data were analyzed separately. Subsequently, combined data were analyzed using scale-adjusted conditional logit latent class models. Models were selected based on the stability of solutions and the Bayesian information criterion. RESULTS: The two latent class model was identified to be optimal for the BWS, DCE, and combined data, and was used to derive tariffs for the ICECAP-SCM capability states. BWS data captured differences in ICECAP-SCM scale levels, whereas DCE data additionally explained interactions between the seven ICECAP-SCM attributes. DISCUSSION: The German ICECAP-SCM tariffs can be used in addition to health-related quality of life to quantify effectiveness in economic evaluations. The tariffs based on BWS data were similar for Germany and the UK, whereas the tariffs based on combined data varied. We would recommend to use tariffs based on combined data in German evaluations. However, only results on BWS data are comparable between Germany and the UK, so that tariffs based on BWS data should be used when comparing results between Germany and the UK.

http://dx.doi.org/10.1007/s10198-020-01260-2

Voir la revue «THE EUROPEAN JOURNAL OF HEALTH ECONOMICS»

Autres numéros de la revue «THE EUROPEAN JOURNAL OF HEALTH ECONOMICS»

Consulter en ligne

Suggestions

Du même auteur

German tariffs for the ICECAP-supportive care...

Article indépendant | DAMS, Judith | THE EUROPEAN JOURNAL OF HEALTH ECONOMICS

OBJECTIVES: Economic evaluations often use preference-based value sets (tariffs) for health-related quality of life to quantify health effects. For wellbeing at the end of life, issues beyond health-related quality of life may be ...

Valuing end-of-life care : translation and co...

Article indépendant | GUHNE, Uta | BMC palliative care | n°1 | vol.20

Background: The evaluation of care strategies at the end of life is particularly important due to the globally increasing proportion of very old people in need of care. The ICECAP-Supportive Care Measure is a self-complete questio...

Effectiveness and feasibility of internet-bas...

Article | ZUELKE, Andrea | JMIR mental health | n°12 | vol.8

Background: Although grief and its symptoms constitute a normal reaction to experiences of loss, some of those affected still report elevated levels of distress after an extended period, often termed complicated grief. Beneficial ...

De la même série

The cost of frailty in France

Article indépendant | SIRVEN, Nicolas | THE EUROPEAN JOURNAL OF HEALTH ECONOMICS | n°2 | vol.18

The objective of the present work is to explore the incremental costs of frailty associated with ambulatory health care expenditures (HCE) among the French population of community-dwellers aged 65 or more in 2012. We make use of a...

Integrating specialist palliative care to imp...

Article indépendant | LOWERS, Jane | BMJ open respiratory research | n°1 | vol.9

Introduction: Cystic fibrosis (CF) is a life-limiting genetic disorder estimated to affect more than 160 000 individuals and their families worldwide. People living with CF commonly experience significant physical and emotional sy...

Specialist palliative care, psychology, inter...

Article indépendant | BARRATT, Shaney L. | BMJ open respiratory research | n°1 | vol.5

Introduction: Patients with progressive idiopathic fibrotic interstitial lung disease (ILD), such as those with idiopathic pulmonary fibrosis (IPF), can have an aggressive disease course, with a median survival of only 3-5 years f...

German tariffs for the ICECAP-supportive care...

Article indépendant | DAMS, Judith | THE EUROPEAN JOURNAL OF HEALTH ECONOMICS

OBJECTIVES: Economic evaluations often use preference-based value sets (tariffs) for health-related quality of life to quantify health effects. For wellbeing at the end of life, issues beyond health-related quality of life may be ...

Evolution of health care utilization and expe...

Article indépendant | TANGUY-MELAC, Audrey | THE EUROPEAN JOURNAL OF HEALTH ECONOMICS

BACKGROUND: Cancer patients have one of the highest health care expenditures (HCE) at the end of life. However, the growth of HCE at the end of life remains poorly documented in the literature. OBJECTIVE: To describe monthly reimb...

Chargement des enrichissements...